Tour de France stage winner Jarlinson Pantano has been suspended after failing a drug test.
The Colombian returned an adverse analytical finding for EPO during an out-of-competition doping control in February.
Pantano’s Trek-Segafredo team said the news is a “deep disappointment.”
In a statement released on Monday (April 15), the team said: “It is with deep disappointment that we have just learned that our rider Jarlinson Pantano has been notified of an adverse analytical finding in a sample collection during an anti-doping control carried out by the Cycling Anti-Doping Foundation.
“In accordance with our zero tolerance policy, he has been suspended immediately.
“We hold our riders and staff to the highest ethical standards and will act and communicate accordingly as more details become available.”
The 30-year-old was tested on February 26, two days after racing the Tour Cyclist International du Haut Var in France.
He returned an adverse analytical finding for Erythropoietin (EPO) in the control, which was carried out by the independent body the Cycling Anti-Doping Foundation which defines and implements anti-doping policy in cycling.
In a statement released on Monday, the UCI said: “The Union Cycliste Internationale (UCI) announces that the Colombian rider Jarlinson Pantano Gomez was notified of an Adverse Analytical Finding (AAF) of Erythropoietin in a sample collected during an out-of-competition control on 26 February 2019.
“In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the affair.
“At this stage of the procedure, the UCI will not comment any further on this matter.”
Pantano can now request that his B sample by analysed.
After turning professional with Colombia-Coldeportes in 2012, Pantano went on to ride for IAM Cycling in 2015 and 2016, before joining Trek in 2017.
He has picked up four wins during his career – a stage of the Tour de Suisse, a stage of the 2016 Tour de France, the Colombian national time trial championship and a stage of last year’s Volta a Catalunya.
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
-
-
Best bicycle insurance, including what you need to know and how to compare
Wondering how to protect your pride and joy? Our helpful guide tells you all you need to know about bicycle insurance
-
Five talking points from stage eleven of the Giro d’Italia 2022
The Cycling Weekly highlights package from the stage which finally saw an Italian win at the home race this year
-
Trial begins into French doctor and two others accused of attempting to dope cyclists
Bernand Sainz has been involved in cycling circles for the best part of six decades
-
Johan Bruyneel: 'Lance Armstrong was the perfect target to be sacrificed' to clean up cycling
The former rider and team boss says in his era the choice was 'either you adapt and you dope yourself, or you disappear'
-
British Paralympic hopeful cyclist banned for three years for doping offence
Erin McBride, who joined the British Cycling team after switching from athletics this year, tested positive for a banned substance
-
Two Italian cyclists banned following doping violations
One was an amateur time trial champion
-
German former rider receives nine year doping ban and stripped of 11 years worth of results
Björn Thurau retired from racing at the end of 2019
-
Doping ban for former Trek-Segafredo rider upheld after his appeal fails
The Court of Arbitration for Sport upheld the four-year ban for the 36-year-old
-
Delko rider banned for doping says he tested positive after eye surgery
A Delko rider banned for doping has claimed he tested positive after having eye surgery.
-
Doctor at centre of Operation Aderlass doping scandal jailed by German court
The doctor at the centre of the Operation Aderlass doping scandal has been jailed by a German court.
